Theme 5: Tissue Engineering for Regenerative Medicine
Table of Contents
- Regenerative Medicine and Its Significance
- Enabling technologies for Regenerative Medicine
- Commercialisation of cell-based products
- Moderating the 'race' to market
- Manufacturing challenges
- Prospective manufacturing models
- Therapeutic targets: How ambitious should we be?
- New Zealand’s Regenerative Medicine position
- A special Regenerative Medicine project
- Market size
- Challenges
- Science and technology comment
- Researchers and entrepreneurs gallery
Researchers and entrepreneurs gallery
The Regenerative Medicine industry in New Zealand has significant research capability and a small but growing clutch of companies moving cell-based medicinal products from their laboratory benches to market. Some of the people at the centre of this activity are introduced below. Others will be introduced in due course. Click to see some of the people at the centre of this activity.
More researchers and entrepreneurs will be listed soon.
- Dr Azam Ali
- Distinguished Professor Margaret Brimble
- Associate Professor Bronwen Connor
- Professor Jillian Cornish and Dr David Musson
- Associate Professor Alan Davidson
- Professor Colin Green and Associate Professor Trevor Sherwin
- Dr John Higgins and Professor Richard Archer
- Dr Kathleen Hofman
- Distinguished Professor Peter Hunter
- Dr Sophia Leung
- Dr Deborah Le Corre-Bordes
- Dr Khoon Lim
- Associate Professor Mervyn Merrilees
- Associate Professor Michael Mucalo
- Dr Ben Schon
- Professor Shane Xie